| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Safety and Tolerability of Adoptive Cell Therapy in Cancer
|
Wolf, Benita
|
|
|
42 |
2 |
p. 315-334
|
artikel
|
| 2 |
Safety and Tolerability of Adoptive Cell Therapy in Cancer
|
Wolf, Benita
|
|
2019
|
42 |
2 |
p. 315-334
|
artikel
|
| 3 |
Safety and Tolerability of Anaplastic Lymphoma Kinase Inhibitors in Non-Small-Cell Lung Cancer
|
Rocco, Danilo
|
|
2019
|
42 |
2 |
p. 199-209
|
artikel
|
| 4 |
Safety and Tolerability of Anti-Angiogenic Protein Kinase Inhibitors and Vascular-Disrupting Agents in Cancer: Focus on Gastrointestinal Malignancies
|
Procaccio, Letizia
|
|
|
42 |
2 |
p. 159-179
|
artikel
|
| 5 |
Safety and Tolerability of Anti-Angiogenic Protein Kinase Inhibitors and Vascular-Disrupting Agents in Cancer: Focus on Gastrointestinal Malignancies
|
Procaccio, Letizia
|
|
2019
|
42 |
2 |
p. 159-179
|
artikel
|
| 6 |
Safety and Tolerability of Antibody-Drug Conjugates in Cancer
|
Wolska-Washer, Anna
|
|
2019
|
42 |
2 |
p. 295-314
|
artikel
|
| 7 |
Safety and Tolerability of c-MET Inhibitors in Cancer
|
Puccini, Alberto
|
|
2019
|
42 |
2 |
p. 211-233
|
artikel
|
| 8 |
Safety and Tolerability of Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitors in Oncology
|
Shah, Rashmi R.
|
|
2019
|
42 |
2 |
p. 181-198
|
artikel
|
| 9 |
Safety and Tolerability of Histone Deacetylase (HDAC) Inhibitors in Oncology
|
Shah, Rashmi R.
|
|
2019
|
42 |
2 |
p. 235-245
|
artikel
|
| 10 |
Safety and Tolerability of Immune Checkpoint Inhibitors (PD-1 and PD-L1) in Cancer
|
Baraibar, Iosune
|
|
2019
|
42 |
2 |
p. 281-294
|
artikel
|
| 11 |
Safety and Tolerability of Immune Checkpoint Inhibitors (PD-1 and PD-L1) in Cancer
|
Baraibar, Iosune
|
|
|
42 |
2 |
p. 281-294
|
artikel
|
| 12 |
Safety and Tolerability of Phosphatidylinositol-3-Kinase (PI3K) Inhibitors in Oncology
|
Curigliano, Giuseppe
|
|
2019
|
42 |
2 |
p. 247-262
|
artikel
|
| 13 |
Safety and Tolerability of Sonic Hedgehog Pathway Inhibitors in Cancer
|
Carpenter, Richard L.
|
|
2019
|
42 |
2 |
p. 263-279
|
artikel
|
| 14 |
Safety of Novel Targeted Therapies in Oncology
|
Shah, Rashmi R.
|
|
2019
|
42 |
2 |
p. 157-158
|
artikel
|
Tijdschrift beschrijving